Xu Weihao 4
4 · CASI Pharmaceuticals, Inc. · Filed Dec 18, 2020
Insider Transaction Report
Form 4
Xu Weihao
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-12-16$2.44/sh+2,000$4,880→ 6,000 total(indirect: By Spouse) - Purchase
Common Stock
2020-12-17$2.63/sh+2,279$5,994→ 10,000 total(indirect: By Spouse) - Purchase
Common Stock
2020-12-17$2.64/sh+1,721$4,543→ 7,721 total(indirect: By Spouse) - Award
Employee Stock Option (Right to Buy)
2020-12-16+800,000→ 800,000 totalExercise: $2.61Exp: 2030-12-16→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]The stock options vest as follows: 160,000 options on each of the first and second anniversaries of the date of grant and 240,000 options on each of the third and fourth anniversaries of the date of grant.